Method of reducing cyclophosphamide induced hemorrhagic cystitis
US5447712A · kind A · utility
3Cited by
35References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 1993 |
| Grant date | Sep 5, 1995 |
| Priority date | — |
| Expiry date | Dec 9, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/675
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for reducing side effects caused by chemotherapeutic agents by administering to a patient in need thereof a therapeutically effective amount of a composition including L-2-oxothiazolidine-4-carboxylate specifically for reducing hemorrhagic cystitis in a patient at risk of same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.